Literature DB >> 22132370

Fatigue as a residual symptom of depression.

Steven D Targum1, Maurizio Fava.   

Abstract

Entities:  

Year:  2011        PMID： 22132370      PMCID： PMC3225130     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN： 2158-8333


× No keyword cloud information.
  11 in total

1.  Residual symptoms in depressed patients who respond acutely to fluoxetine.

Authors:  A A Nierenberg; B R Keefe; V C Leslie; J E Alpert; J A Pava; J J Worthington; J F Rosenbaum; M Fava
Journal:  J Clin Psychiatry       Date:  1999-04       Impact factor: 4.384

2.  Reliability and validity of the Massachusetts general hospital cognitive and physical functioning questionnaire.

Authors:  Maurizio Fava; Dan V Iosifescu; Paola Pedrelli; Lee Baer
Journal:  Psychother Psychosom       Date:  2009-02-13       Impact factor: 17.659

3.  The Fatigue Questionnaire: Standardization in patients with major depression.

Authors:  Panagiotis Ferentinos; Vassilis Kontaxakis; Beata Havaki-Kontaxaki; Dimitris Dikeos; George Papadimitriou
Journal:  Psychiatry Res       Date:  2010-04-09       Impact factor: 3.222

Review 4.  Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.

Authors:  George I Papakostas; David J Nutt; Lindsay A Hallett; Vivian L Tucker; Alok Krishen; Maurizio Fava
Journal:  Biol Psychiatry       Date:  2006-08-24       Impact factor: 13.382

5.  A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.

Authors:  Maurizio Fava; Michael E Thase; Charles DeBattista
Journal:  J Clin Psychiatry       Date:  2005-01       Impact factor: 4.384

Review 6.  The future of psychopharmacology of depression.

Authors:  Trina Chang; Maurizio Fava
Journal:  J Clin Psychiatry       Date:  2010-08       Impact factor: 4.384

Review 7.  Symptoms of fatigue and sleepiness in major depressive disorder.

Authors:  David S Baldwin; George I Papakostas
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

Review 8.  Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment.

Authors:  Maurizio Fava
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

9.  RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ).

Authors:  Gregory M Chandler; Dan V Iosifescu; Mark H Pollack; Steven D Targum; Maurizio Fava
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

Review 10.  Understanding fatigue in major depressive disorder and other medical disorders.

Authors:  Lesley M Arnold
Journal:  Psychosomatics       Date:  2008 May-Jun       Impact factor: 2.386
View more
  28 in total

1.  Tyrosine metabolism during interferon-alpha administration: association with fatigue and CSF dopamine concentrations.

Authors:  Jennifer C Felger; Li Li; Paul J Marvar; Bobbi J Woolwine; David G Harrison; Charles L Raison; Andrew H Miller
Journal:  Brain Behav Immun       Date:  2012-10-13       Impact factor: 7.217

Review 2.  Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Authors:  J C Felger; F E Lotrich
Journal:  Neuroscience       Date:  2013-05-03       Impact factor: 3.590

Review 3.  Inflammation Effects on Motivation and Motor Activity: Role of Dopamine.

Authors:  Jennifer C Felger; Michael T Treadway
Journal:  Neuropsychopharmacology       Date:  2016-08-02       Impact factor: 7.853

4.  Personalized prognostic prediction of treatment outcome for depressed patients in a naturalistic psychiatric hospital setting: A comparison of machine learning approaches.

Authors:  Christian A Webb; Zachary D Cohen; Courtney Beard; Marie Forgeard; Andrew D Peckham; Thröstur Björgvinsson
Journal:  J Consult Clin Psychol       Date:  2020-01

5.  Satisfaction with life in adults with Marfan syndrome (MFS): associations with health-related consequences of MFS, pain, fatigue, and demographic factors.

Authors:  Gry Velvin; Trine Bathen; Svend Rand-Hendriksen; Amy Østertun Geirdal
Journal:  Qual Life Res       Date:  2016-01-04       Impact factor: 4.147

Review 6.  Activational and effort-related aspects of motivation: neural mechanisms and implications for psychopathology.

Authors:  John D Salamone; Samantha E Yohn; Laura López-Cruz; Noemí San Miguel; Mercè Correa
Journal:  Brain       Date:  2016-05       Impact factor: 13.501

7.  Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-α treatment.

Authors:  Francis E Lotrich; Salwa Albusaysi; Robert E Ferrell
Journal:  Neuropsychopharmacology       Date:  2012-12-18       Impact factor: 7.853

8.  The effect of red-blood-cell transfusion on fatigue in hospitalized patients with anaemia.

Authors:  Micah T Prochaska; Richard Newcomb; David Jiang; David O Meltzer
Journal:  Vox Sang       Date:  2018-09-04       Impact factor: 2.144

Review 9.  Molecular insights into the therapeutic promise of targeting HMGB1 in depression.

Authors:  Tarapati Rana; Tapan Behl; Vineet Mehta; Md Sahab Uddin; Simona Bungau
Journal:  Pharmacol Rep       Date:  2020-10-04       Impact factor: 3.024

Review 10.  The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation.

Authors:  Larissa N Dooley; Kate R Kuhlman; Theodore F Robles; Naomi I Eisenberger; Michelle G Craske; Julienne E Bower
Journal:  Neurosci Biobehav Rev       Date:  2018-09-07       Impact factor: 8.989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.